Expanding Nilotinib Access in Clinical Trials (ENACT) study in adult patients with imatinib-resistant or -intolerant Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in chronic phase (CP), accelerated phase (AP), or blast crisis (BC): Updated safety analysis

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Nicolini, FE; Alimena, G; Al-Ali, H; Zaritskey, AY; Shen, Z; Jootar, S; Smith, G; Hsu, Y; Veronese, ML; Rizzieri, DA

Published Date

  • May 20, 2008

Published In

Volume / Issue

  • 26 / 15_suppl

Start / End Page

  • 7059 - 7059

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2008.26.15_suppl.7059

Language

  • en